Longeveron Inc. (LGVN) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, greetings and welcome to the Longevron 2026 first quarter financial results and business update call. At this time, all participants are in listen-only mode. A brief question and answer session will follow the formal presentation. If anyone requires operator assistance during the conference call, please signal the operator by pressing star and zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Derek Cole, from Investor Relations at Y3 Solutions. Please go ahead. Thank you, Operator. Good afternoon, everyone, and thank you for joining us today to review Longevron's 2026 First Quarter Financial Results and Business Update. After the U.S. markets today, we issued a press release with financial results for the first quarter, which can be found under the Investor section of the Longevron website. On the call today are Stephen Willard, Chief Executive Officer, Joshua Herr, Co-Founder, Chief Science Officer and Executive Chairman of the Board, Natalia Agafonova, Chief Medical Officer, and Lisa Locklear, Chief Financial Officer. As a reminder, during this call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from these statements. Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors. discussed in the company's filings with the Securities and Exchange Commission, which we encourage you to review. Following the company's prepared remarks, we will open the call to questions from covering research analysts. With that, let me hand over the call to Stephen Willard, Chief Executive Officer. Steve? Thank y...